GILLIS STEVEN
SEC CIK 1229592 · EDGAR
BoughtSold
Most active insiders at TAK, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Plump Andrew Stewart | Pres, R, D, Dir | — | $5.34M |
| 2 | Kim Julie So-Young | Pres, CEO, Dir | — | $1.52M |
| 3 | Duprey Lauren Rusckowski | Chief Transformation Off | — | $1.45M |
| 4 | Greenway Nicola Deidre Petal | CHRO | — | $956.7K |
| 5 | Bitetti Teresa Marie | Pres, OBU | — | $855.2K |
| 6 | Platford Giles Richard | Pres, IBU | — | $531.5K |
| 7 | Furney Natalie Anne Marie | Gbl GC | — | $527.8K |
| 8 | Ricci Gabriele | Chief Data, Tech. Off | — | $429.0K |
| 9 | Shannon Elaine Mary | Pres, Gbl Supply, Quality | — | $425.4K |
| 10 | Pignagnoli Agosti Marcello | Head, Strat, Port. Dev | — | $392.6K |
| 23 | GILLIS STEVEN | Dir | — | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-07-06 18:29 | 2026-07-01 | TAK | TAKEDA PHARMACEUTICAL CO LTD | GILLIS STEVEN | Dir | A - Grant | $0.00 | +3,800 | 10.4K | +58% | $0 |
| I | 2025-08-01 | 2025-08-01 | PRME | Prime Medicine, Inc. | GILLIS STEVEN | 10% | P - Purchase | $3.30 | +3.03M | 6.23M | +95% | +$10.00M |
| DMI | 2024-04-04 | 2024-04-02 | BOLD | Boundless Bio, Inc. | GILLIS STEVEN | 10% | P - Purchase | $16.00 | +200.0K | 683.8K | +41% | +$3.20M |
| DMI | 2024-04-04 | 2024-04-02 | BOLD | Boundless Bio, Inc. | GILLIS STEVEN | 10% | C - Cnv Deriv | — | +2.43M | 1.05M | New | — |
Purchase Sale Sale after option exercise All abbreviations